Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence.

Department of Surgery, University of Toronto, Ontario, Canada.
Archives of Surgery (Impact Factor: 4.3). 03/1999; 134(2):170-6.
Source: PubMed

ABSTRACT To determine the comparative efficacy of selective decontamination of the digestive tract in critically ill surgical and medical patients, and in selected subgroups of surgical patients with pancreatitis, major burn injury, and those undergoing major elective surgery and transplantation.
The MEDLINE database was searched from January 1966 to December 1996 using the terms "decontamination or prophylaxis," "intensive care units," and "antibiotics." The search was limited to English-language studies evaluating the efficacy of selective decontamination of the digestive tract in human subjects.
The primary review was restricted to prospective randomized trials.
End points of interest included rates of nosocomial pneumonia, bacteremia, urinary tract infection, wound infection, mortality, and length of intensive care unit stay. Methodologic quality of individual studies was assessed using a previously described model.
Odds ratios (ORs) together with their (95% confidence interval [Cls]) were reported and determined using the Mantel-Haenszel method. Mortality was significantly reduced with the use of selective decontamination of the digestive tract in critically ill surgical patients (OR, 0.7, 95% CI, 0.52-0.93), while no such effect was demonstrated in critically ill medical patients (OR, 0.91; 95% CI, 0.71-1.18). The greatest effect was demonstrated in studies where both the topical and systemic components of the regimen were used. Rates of pneumonia were reduced in both subsets of patients, while those of bacteremia were significantly reduced only in surgical patients.
Selective decontamination of the digestive tract notably reduces mortality in critically ill surgical patients, while critically ill medical patients derive no such benefit. These data suggest that the use of selective decontamination of the digestive tract should be limited to those populations in whom rates of nosocomial infection are high and in whom infection contributes notably to adverse outcome.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial translocation after major burns plays an important role in burn sepsis and can be reduced with SDD. 30 patients with burns of 25-50% TBSA were divided into 2 groups. Group I received SDD regimen in the form of amikacin, miconazole, and colistin sulphate. Group II served as a control group. SDD treatment resulted in significant control of infectious episodes and multi-organ dysfunction syndrome (MODS). It also resulted in a reduction of mortality, although this was not statistically significant. Despite the statistical insignificance of the improved mortality rate, SDD treatment seems to be a useful tool in treating this group of highly critical patients.
    The Annals of Fires and Burn Disaster 12/2013; 26(4):182-188.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial and fungal infections are a major cause of morbidity and mortality following liver transplantation (LT). The role of intestinal decontamination in the prevention of infections post-LT is controversial. Rifaximin is widely used for the treatment of hepatic encephalopathy. The effect of rifaximin on post-LT infections is unknown. The aim of our study was to determine the effect of rifaximin therapy in the pre-transplant period on early bacterial (EBIs) and fungal infections within 30 days post-LT. All adult patients who underwent LT at our institution (January 2009 -July 2011) were included in this retrospective cohort study. Patients receiving antibiotics other than pre-transplant protocol antibiotics were excluded. Patients were stratified into two groups based on the presence or absence of rifaximin therapy for at least two days before LT. Infections were defined by isolation of any bacterial or fungal organisms within 30 days of LT. Multivariate regression analysis, student's t-tests and Pearson's chi-square tests were used to compare the two groups. Two hundred and sixty eight patients were included, of whom 71 (26.5%) were on rifaximin at the time of LT. Both groups were comparable in age, gender, race and MELD score. There was no significant difference in the rates of EBIs (30% in non-rifaximin group and 25% in rifaximin group, p=0.48) or fungal infections between the two groups. There was no increase in antimicrobial resistance among the infecting organisms. There was no difference in survival between rifaximin and non-rifaximin group (98% versus 97%, P=0.31). The use of rifaximin in the pre-LT period was not associated with an increased risk of bacterial or fungal infections in the early post-LT period. Liver Transpl , 2014. © 2014 AASLD.
    Liver Transplantation 05/2014; 20(5). DOI:10.1002/lt.23845 · 3.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Evidence supporting selective decontamination of the digestive tract (SDD) is reasonably strong. We set out to determine use in UK critical care units and to compare patient outcomes between units that do and those that do not use SDD. A total of 250 UK general critical care units were surveyed. Case mix, outcomes, and lengths of stay for admissions to SDD units (with and without an i.v. component) and non-SDD units were compared using data from the Intensive Care National Audit & Research Centre Case Mix Programme database. A response was received from all the 250 critical care units surveyed. Of these, 13 (5.2%) reported using SDD on some or all admissions, and of these, 3 reported using an i.v. component. Data on 284 690 admissions (April 2008-March 2011) from units reporting to the ICNARC Case Mix Programme (CMP) were included in the analyses. Admissions to SDD (n=196) and non-SDD (n=9) units were a similar case mix with similar infection rates and average lengths of stay in the unit and hospital. There was no difference in risk-adjusted unit or hospital mortality. The rate of unit-acquired infections in blood was significantly lower in SDD units using an i.v. component. Use of SDD in UK critical care is very low. The rate of unit-acquired infections in blood was significantly lower in SDD units using an i.v. component, but did not translate into a difference in acute hospital mortality or length of stay. There is a need to better understand the barriers to adoption of SDD into clinical practice and such work is underway.
    BJA British Journal of Anaesthesia 05/2014; 113(4). DOI:10.1093/bja/aeu108 · 4.35 Impact Factor


Available from